1177 results found.
1H17 Funding Recap: Investors Continue to Back Regulatory-Approved Orthopaedic Technologies
The 22 funding announcements we tracked by orthopaedic companies in 1H17 kept pace with the number of announcements made in the first halves of 2016 and 2015, signaling that the environment to raise capital remains consistent, but difficult. Risk-adverse private equity, venture capital and other ...
Carmell Therapeutics Issued Canada Patent to Support Plasma-based Materials
Carmell Therapeutics was issued Canada Patent No. 2,701,187, addressing Methods and Apparatus for Manufacturing Plasma B...
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Creative Medical Expands IP for its Cell-based Lower Back Pain Treatment
Creative Medical filed two patent applications regarding use of immune system cells to stimulate blood...
BONESUPPORT commenced trading on Nasdaq Stockholm following completion of its IPO.
Extremity Medical Launches BioFuse Viable Cell Bone Graft
Extremity Medical launched BioFuse, a next-gen viable cell bone graft for use in the foot, ankle, wrist and han...
Bone Therapeutics Completes Recruitment in PREOB Phase III Trial
Bone Therapeutics completed patient recruitment for interim analysis in its Phase III trial of
Creative Medical Seeks to Augment MSC Therapies for Low Back Pain
Creative Medical Technology filed a patent application covering synergy between intradiscal stem cell injections
ASC Biosciences to Receive $1.5MM Funding for Stem Cell Platform
ASC Biosciences partnered with Stem Cell Development Fund to receive US $1.5MM to support development and marketi...
Premier to Offer Bioventus Surgical Orthobiologics Products to Members
Premier is now offering Bioventus' full surgical orthobiologics product portfolio to its U.S. membership...
FDA 510(k) Clearance for Prosidyan FIBERGRAFT BG Putty
Prosidyan received FDA 510(k) clearance of FIBERGRAFT BG Putty for use in posterolateral spinal fusion. 
Ortho-ACI Approved on the Australian Register of Therapeutic Goods
Orthocell received confirmation that Ortho-ACI® Autologous Chondrocyte Implantation is included on the ...
Hyalex Orthopaedics Raises $16 Million Series A Financing
Hyalex Orthopaedics raised US $16MM in a Series A financing. The company is developing HYALEX™
Medtronic Reports FY4Q17 Revenue
ORTHOWORLD estimates Medtronic’s FY4Q17 revenue at US $759.0MM, +3.0% vs. FY4Q16.
Anika Announces Enrolls First Patient in Supplemental Phase III CINGAL Trial
Anika Therapeutics enrolled the first patient in a supplemental Phase III trial evaluating CINGAL
SurGenTec Receives US Patent for GRAFTGUN
SurGenTec was granted U.S. Patent No. 9,655,748, Bone Graft Delivery System and Method for Using Same, pertaining to the GRAFT...
CINGAL Phase III Data Demonstrates Efficacy and Safety to Treat Knee OA Pain
Phase III study results demonstrated that Anika Therapeutics' CINGAL® provided superior immediate and short term OA pain...
Vericel Signs Distribution Agreement with Orsini Pharmaceutical
Vericel entered into a 2-year renewable agreement with Orsini Pharmaceutical for distribution of Cartice...
BONESUPPORT Enrolls First Patient in FORTIFY Trial With CERAMENT G
BONESUPPORT enrolled the first patient in the pivotal IDE trial of CERAMENT G in the surgical re...
Rotation Medical BioInductive Implant REBUILD Study Results
Interim study results indicate that patients receiving Rotation Medical's Bioinductive Implant to treat rotator cuff disease
Amend Surgical Receives Funding from Florida State
Amend Surgical entered into a funding agreement in support of products for the bone graft substitute market.
Stryker to Distribute AlloSource Products for Sports Medicine Procedures
Stryker entered into an agreement to distribute AlloSource biologic products in the U.S. for ...
Seikagaku Posts 4QFY16 Revenue
Seikagaku posted 4QFY16 revenue of ¥7.5BB (~US $75.6MM), -6.6% vs. the prior year.
Seikagaku Enters Collaboration on SI-613 in Japan
Seikagaku entered into a basic co-development and marketing collaboration with Ono Pharmaceutical in Japan for...
Alphatec Spine Reports 1Q17 Revenue
Alphatec Spine posted 1Q17 revenue of US $28.0MM, -18.2% vs. 1Q16.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2017 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group